Resources
About Us
Home Report
Store
High Throughput Screening Market
High Throughput Screening Market by Technology (Cell-based Assays [2D, 3D], Label-free, Lab-on-chip), Offering (Reagents, Liquid Handling, Readers, Sample Prep), Application (Target Identification, Toxicology, Stem Cell), End User - Global Forecast to 2031
Report ID:MRHC - 10443 Pages: 250 Mar-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 48 HoursThe High Throughput Screening Market was valued at $22.15 billion in 2023. This market is expected to reach $47.41 billion by 2031, from an estimated $24.18 billion in 2024, at a CAGR of 10.1% during the forecast period 2024-2031.
High Throughput Screening Market Size & Forecast
High throughput screening (HTS) or high-throughput experimentation (HTE) is used to carry out many reactions simultaneously in parallel synthesis. HTS assays are specifically useful for efficient and rapid screening of compounds to find the ideal reactants for the reaction. High-throughput screening methods frequently use automated systems such as computer programs, robotic plating systems, and automated data collection/analysis for the identification of potential reactants. HTS has transformed the drug discovery process and is used by research laboratories, pharmaceutical companies, academic institutions, and other end users to identify new potential drug candidates.
Increasing Funding for Drug Discovery is Driving the Market Growth
Pharmaceutical and biotechnology companies allocate significant resources to drug discovery. For instance, in 2022, the R&D spending of F Merck KGaA (Germany) increased by 10.6% from 2021. The rise in the company’s R&D expenditure was attributed to the increased focus on the cardiovascular drug portfolio. Similarly, Pfizer (U.S.) increased R&D expenditure in 2022 by 10% from 2021. High throughput screening is majorly used for the detection of compounds known as hits with biological or pharmacological activity. The hits are considered as a starting point for drug discovery & development.
Along with the pharmaceutical & biotechnology companies, government agencies across the globe are also allocating funding for drug discovery, which, in turn, is expected to drive the growth of the high throughput screening market. For instance, according to the National Venture Capital Association, venture capital investments and funding for biotech and pharmaceutical companies in the U.S. reached USD 30.7 billion in 2022 from USD 18.7 billion in 2019. Following are some of the recent investments/funding for drug discovery:
- In June 2023, the Commonwealth Government’s Medical Research Future Fund (MRFF) (Australia) invested USD 9.75 million to establish MedChem Australia, a new national medicinal chemistry initiative. This funding aims to accelerate the identification of early-stage drug candidates.
- In July 2022, the Council of Scientific and Industrial Research (CSIR) (India) invested USD 6.73 million in R&D activities for drug discovery and development.
- In November 2021, the Medical Research Agency (Poland) announced USD 73.3 million (PLN 300 million) in funding to help produce vaccines based on mRNA technology in Poland.
Click here to: Get Free Sample Pages of this Report
Multiplexed High Throughput Screening Assay is a Recent Trend in the HTS Market
High throughput analysis is a crucial technique frequently used in the early stages of drug discovery to select small subsets of vast chemical libraries that regulate the activity of a biological target. To discover the most promising compounds rapidly, effectively, and affordably, HTS needs scalable, high-quality assays. Multiplex assays analyze several targets in a single well with small amounts of sample, dramatically increasing the data points gathered in HTS. Multiplex assays enable simultaneous measurement of many analytes, giving researchers more information from a single assay. They can reduce a researcher's workload while speeding up and scaling up biomarker profiling.
Multiplexing and high-throughput capabilities combined in high-throughput multiplex assays allow for the collection of more meaningful data and the improvement of early drug discovery decision-making without compromising test performance or data quality.
Performing HTS assay in multiplexed format increases the speed and efficiency of the drug discovery process as more than one piece of information can be obtained from each assay performed. A multiplexed format also lowers costs and variability as assays are completed using the same parameters. The lowering variability of the assay results also decreases the potential incidences of obtaining false positive results, thus increasing the accuracy of the drug discovery process.
Additionally, the key players are launching the multiplexed HTS assay. For instance, in February 2022, Bruker Corporation (U.S.) launched a High-Throughput Multiplex HTS on the Sierra SPR Platform. The microfluidic system of the Bruker Sierra SPR-32 Pro provides a unique 8x4 array for parallel readout of 32 measurement sensor spots per injection at exceptional robustness. This configuration offers high throughput while maintaining flexibility for the development of both biologics and small-molecule drug candidates.
Key Findings in the Global High Throughput Screening Market Study:
Based on Offerings, the Software & Services Segment is Projected to Register the Highest CAGR During the Forecast Period
Based on offerings, the high throughput screening market is segmented into consumables & reagents, instruments, and software & services. The software & services segment is expected to register the highest CAGR during the forecast period. The high CAGR of the segment is attributed to the increasing adoption of software for the data analysis obtained through the HTS. Additionally, HTS leverages the automation in instruments such as liquid handling systems, which require data processing software.
Based on Technologies, in 2024, the Cell-based Assay Segment is Expected to Account for the Largest Share of the Market
Based on technologies, the high throughput screening market is segmented into cell-based assays, ultra-high throughput screening, label-free technology, and lab-on-chip. In 2024, the cell-based assays segment is expected to account for the largest share of the high throughput screening market. The use of cell-based assays in drug-discovery screening applications and biomedical research to quantify off-target interactions, cytotoxicity, and biochemical mechanisms is attributed to the largest share of the segment. The benefits associated with high throughput cell-based assays, such as physiological relevance, generation of more data, and the ability to simultaneously measure compound characteristics, are also supporting the segment's large share.
Based on Applications, the Target Identification Segment is Expected to Account for the Largest Share of the Market
Based on applications, the high throughput screening market is segmented into stem cell research, toxicology assessment, target identification, and primary screening. In 2024, the target identification segment is expected to account for the largest share of the high throughput screening market. The large share of the segment is attributed to the increased adoption of high throughput products for the efficient, cost-effective, and accurate identification of targets in the early stage of drug discovery. Additionally, increasing drug failure rate during clinical trials due to drug toxicity and lack of drug efficacy is increasing the demand for target identification. Additionally, HTS is also used in cases where the structure information of the target molecule is not known, thus providing the flexibility of target identification from a large number of molecules.
Based on End Users, the Pharmaceutical and Biotechnology Industry Segment is Expected to Account for the Largest Share of the Market
Based on end users, the high throughput screening market is segmented into pharmaceutical and biotechnology industry, academics and research institutes, and contract research organizations. In 2024, the pharmaceutical & biotechnology industry segment is expected to account for the largest share of the high throughput screening market. The large market share of this segment is attributed to the need to develop new therapies owing to increasing disease prevalence and increased spending on pharmaceutical R&D. For instance, global pharmaceutical R&D expenditure is expected to reach USD 213 billion in 2026 from USD 179 billion in 2020 (Source: International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)). Additionally, pharmaceutical & biotechnology companies' shift from traditional screening methods to HTS is contributing to the large share of the segment.
North America: Largest Regional Market
In 2024, North America is expected to account for the largest share of the high throughput screening market. North America's significant market share is attributed to several factors, including substantial R&D investments by pharmaceutical and biotechnology companies for drug and biomarker development, a growing prevalence of chronic diseases, increased healthcare expenditure, the presence of key market players in the region, and government initiatives supporting research and development. The surge in R&D spending by pharmaceutical companies is anticipated to drive the demand for high throughput screening, driving the market. According to the European Federation of Pharmaceutical Industries and Associations (Belgium), in the U.S., the pharmaceutical R&D expenditure annual growth rate was 15.6% from 2018-2022 compared to 13.6% from 2013-2017.
High Throughput Screening Market: Competitive Analysis
The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past few years 2020–2024. The key players operating in the global high throughput screening market are Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Revvity Inc. (U.S.), Tecan Group Ltd. (Switzerland), Axxam S.p.A. (Italy), Charles River Laboratories International, Inc. (U.S.), Hamilton Company (U.S.), Promega Corporation (U.S.), and Aurora Biomed Inc. (Canada).
High Throughput Screening Market Report Summary:
|
Particulars |
Details |
|
Number of Pages |
~250 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
10.1% |
|
Estimated Market Size (Value) |
$47.41 billion by 2031 |
|
Segments Covered |
By Product
By Offerings
By Application
By End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and RoE), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa |
|
Key Companies |
Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Revvity Inc. (U.S.), Tecan Group Ltd. (Switzerland), Axxam S.p.A. (Italy), Charles River Laboratories International, Inc. (U.S.), Hamilton Company (U.S.), Promega Corporation (U.S.), and Aurora Biomed Inc. (Canada). |
Key questions answered in the report:
The global high throughput screening market covers the study of various technologies and offerings in HTS for multiple applications used across end users. This report also involves the analysis of various segments of high throughput screening at the regional and country levels.
The High Throughput Screening Market is projected to reach $47.41 billion by 2031 at a CAGR of 10.1% from 2024 to 2031.
Among all the offerings studied in this report, in 2024, the consumables & reagents segment is expected to account for the largest share of the high throughput screening market. The wide availability of reagents and kits and their recurrent use at various stages in drug discovery are supporting the large share of consumables & reagents in the market.
Among all the applications studied in this report, in 2024, the target identification segment is expected to account for the largest share of the high throughput screening market. The large share of the segment is attributed to the increased adoption of high throughput products for the efficient, cost-effective, and accurate identification of targets in the early stage of drug discovery.
The growth of this market can be attributed to various factors, such as the increasing adoption of innovative approaches for R&D in pharmaceutical and biotechnology companies, increasing funding for drug discovery, increasing number of drug targets for screening, and the rising number of HTS facilities.
Furthermore, the expansion of the biotechnology sector in countries like Singapore and India and technological advancements in HTS are expected to offer market growth opportunities.
The key players operating in the global HTS market are Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Revvity Inc. (U.S.), Tecan Group Ltd. (Switzerland), Axxam S.p.A. (Italy), Charles River Laboratories International, Inc. (U.S.), Hamilton Company (U.S.), Promega Corporation (U.S.), and Aurora Biomed Inc. (Canada).
The countries in Asia-Pacific are projected to offer significant growth opportunities for the vendors in this market. China and India are boosting their investment in research and development in the healthcare sector. Chinese pharmaceutical & biopharmaceutical companies are actively seeking new products and technologies through drug discovery and development to meet the rising medical demand for innovative products from the large patient population in the country. Moreover, significantly growing pharmaceutical research outsourcing from the country is positively impacting the high throughput screening market. Additionally, the rising drug discovery market and collaboration of key companies with domestic companies for drug discovery in South Korea are offering opportunities for market growth.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Adoption of Innovative Approaches for R&D in Pharmaceutical and Biotechnology Companies
4.2.2. Increasing Funding for Drug Discovery
4.2.3. Increasing Number of Drug Targets for Screening
4.2.4. Rising Number of HTS Facilities
4.3. Restraint
4.3.1. High Capital Investment
4.3.2. Government Regulations for Drug Development
4.4. Opportunities
4.4.1. Expansion of Biotechnology Sector in Countries Like Singapore and India
4.4.2 Technological Advancements in HTS
4.5. Challenges
4.5.1. Complexity in HTS Data Handling
4.5.2. Potential False Positive Results
4.6. Factor Analysis
4.7. Trends
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Porter’s Five Force Analysis
5. High Throughput Screening Market Assessment—by Technology
5.1. Overview
5.2. Cell-Based Assays
5.2.1. 2D Cell Culture
5.2.2. 3D Cell Culture
5.2.2.1. Scaffold Based Technology
5.2.2.1.1. Natural Polymer Hydrogels
5.2.2.1.1.1. Collagen
5.2.2.1.1.2. Gelatin
5.2.2.1.1.3. Hyaluronic Acid
5.2.2.1.1.4. Alginate
5.2.2.1.2. Synthetic Polymers
5.2.2.1.3. Solid Scaffolds
5.2.2.2. Scaffold Free Technology
5.2.2.2.1. Hanging Drop Plates
5.2.2.2.2. Microfluidics
5.2.2.2.3. Rotating Wall Vessel
5.2.2.2.4. Other Scaffold Free Technologies
5.2.3. Perfusion Cell Culture
5.3. Ultra-High Throughput Screening
5.4. Label-free Technology
5.5. Lab-on-Chip
6. High Throughput Screening Market Assessment—by Offering
6.1. Overview
6.2. Consumables & Reagents
6.3. Instruments
6.3.1. Sample Preparation Instruments & Accessories
6.3.2. Liquid Handling Instruments
6.3.3. Readers
6.3.4. Other Instruments
6.4. Software & Services
7. High Throughput Screening Market Assessment—by Application
7.1. Overview
7.2. Stem Cell Research
7.3. Toxicology Assessment
7.4. Target Identification
7.5. Primary Screening
8. High Throughput Screening Market Assessment—by End User
8.1. Overview
8.2. Pharmaceutical and Biotechnology Companies
8.3. Contract Research Organizations (CROs)
8.4. Academic and Research Institutes
9. High Throughput Screening Market Assessment—by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America (RoLATAM)
9.6. Middle East & Africa
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis/Market Ranking, by Key Players (2023)
11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1. Thermo Fisher Scientific Inc.
11.2. Agilent Technologies, Inc.
11.3. Merck KGaA
11.4. Danaher Corporation
11.5. Bio-Rad Laboratories, Inc.
11.6. Revvity Inc.
11.7. Tecan Group Ltd.
11.8. Axxam S.p.A.
11.9. Charles River Laboratories International, Inc.
11.10. Hamilton Company
11.11. Promega Corporation
11.12. Aurora Biomed Inc
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Global High Throughput Screening Market, by Technology, 2022–2031 (USD Million)
Table 2 Global High Throughput Screening Market for Cell-based Assays, by Type, 2022–2031 (USD Million)
Table 3 Global High Throughput Screening Market for Cell-based Assays, by Country/Region, 2022–2031 (USD Million)
Table 4 Global High Throughput Screening Market for 2D Cell Culture, by Country/Region, 2022–2031 (USD Million)
Table 5 Global High Throughput Screening Market for 3D Cell Culture, by Type, 2022–2031 (USD Million)
Table 6 Global High Throughput Screening Market for 3D Cell Culture, by Country/Region, 2022–2031 (USD Million)
Table 7 Global High Throughput Screening Market for Scaffold-based Technology, by Type, 2022–2031 (USD Million)
Table 8 Global High Throughput Screening Market for Scaffold-based Technology, by Country/Region, 2022–2031 (USD Million)
Table 9 Global High Throughput Screening Market for Natural Polymer Hydrogels, by Type, 2022–2031 (USD Million)
Table 10 Global High Throughput Screening Market for Natural Polymer Hydrogels, by Country/Region, 2022–2031 (USD Million)
Table 11 Global High Throughput Screening Market for Collagen, by Country/Region, 2022–2031 (USD Million)
Table 12 Global High Throughput Screening Market for Gelatin, by Country/Region, 2022–2031 (USD Million)
Table 13 Global High Throughput Screening Market for Hyaluronic Acid, by Country/Region, 2022–2031 (USD Million)
Table 14 Global High Throughput Screening Market for Alginate, by Country/Region, 2022–2031 (USD Million)
Table 15 Global High Throughput Screening Market for Synthetic Polymers, by Country/Region, 2022–2031 (USD Million)
Table 16 Global High Throughput Screening Market for Solid Scaffolds, by Country/Region, 2022–2031 (USD Million)
Table 17 Global High Throughput Screening Market for Scaffold Free Technology, by Type, 2022–2031 (USD Million)
Table 18 Global High Throughput Screening Market for Scaffold Free Technology, by Country/Region, 2022–2031 (USD Million)
Table 19 Global High Throughput Screening Market for Hanging Drop Plates, by Country/Region, 2022–2031 (USD Million)
Table 20 Global High Throughput Screening Market for Microfluidics, by Country/Region, 2022–2031 (USD Million)
Table 21 Global High Throughput Screening Market for Rotating Wall Vessels, by Country/Region, 2022–2031 (USD Million)
Table 22 Global High Throughput Screening Market for Other Scaffold Free Technology, by Country/Region, 2022–2031 (USD Million)
Table 23 Global High Throughput Screening Market for Perfusion Cell Culture, by Country/Region, 2022–2031 (USD Million)
Table 24 Global High Throughput Screening Market for Ultra-high Throughput Screening, by Country/Region, 2022–2031 (USD Million)
Table 25 Global High Throughput Screening Market for Label-free Technology, by Country/Region, 2022–2031 (USD Million)
Table 26 Global High Throughput Screening Market for Lab On Chip, by Country/Region, 2022–2031 (USD Million)
Table 27 Global High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 28 Global High Throughput Screening Consumables & Reagents Market, by Country/Region, 2022–2031 (USD Million)
Table 29 Global High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 30 Global High Throughput Screening Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 31 Global High Throughput Sample Preparation Instruments & Accessories Market, by Country/Region, 2022–2031 (USD Million)
Table 32 Global High Throughput Liquid Handling Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 33 Global High Throughput Readers Market, by Country/Region, 2022–2031 (USD Million)
Table 34 Global High Throughput Other Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 35 Global High Throughput Software & Services Market, by Country/Region, 2022–2031 (USD Million)
Table 36 Global High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 37 Global High Throughput Screening Market for Stem Cell Research, by Country/Region, 2022–2031 (USD Million)
Table 38 Global High Throughput Screening Market for Toxicology Assessment, by Country/Region, 2022–2031 (USD Million)
Table 39 Global High Throughput Screening Market for Target Identification, by Country/Region, 2022–2031 (USD Million)
Table 40 Global High Throughput Screening Market for Primary Screening, by Country/Region, 2022–2031 (USD Million)
Table 41 Global High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 42 Global High Throughput Screening Market for Pharmaceutical and Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 43 Global High Throughput Screening Market for CRO, by Country/Region, 2022–2031 (USD Million)
Table 44 Global High Throughput Screening Market for Academic and Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 45 Global High Throughput Screening Market, by Country/Region, 2022–2031 (USD Million)
Table 46 North America: High Throughput Screening Market, by Country, 2022–2031 (USD Million)
Table 47 North America: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 48 North America: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 49 North America: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 50 North America: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 51 North America: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 52 North America: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 53 North America: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 54 North America: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 55 North America: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 56 North America: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 57 U.S.: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 58 U.S.: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 59 U.S.: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 60 U.S.: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 61 U.S.: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 62 U.S.: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 63 U.S.: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 64 U.S.: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 65 U.S.: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 66 U.S.: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 67 Canada: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 68 Canada: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 69 Canada: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 70 Canada: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 71 Canada: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 72 Canada: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 73 Canada: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 74 Canada: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 75 Canada: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 76 Canada: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 77 Europe: High Throughput Screening Market, by Country/Region, 2022–2031 (USD Million)
Table 78 Europe: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 79 Europe: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 80 Europe: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 81 Europe: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 82 Europe: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 83 Europe: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 84 Europe: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 85 Europe: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 86 Europe: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 87 Europe: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 88 Germany: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 89 Germany: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 90 Germany: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 91 Germany: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 92 Germany: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 93 Germany: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 94 Germany: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 95 Germany: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 96 Germany: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 97 Germany: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 98 France: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 99 France: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 100 France: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 101 France: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 102 France: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 103 France: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 104 France: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 105 France: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 106 France: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 107 France: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 108 U.K.: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 109 U.K.: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 110 U.K.: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 111 U.K.: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 112 U.K.: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 113 U.K.: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 114 U.K.: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 115 U.K.: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 116 U.K.: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 117 U.K.: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 118 Italy: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 119 Italy: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 120 Italy: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 121 Italy: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 122 Italy: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 123 Italy: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 124 Italy: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 125 Italy: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 126 Italy: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 127 Italy: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 128 Spain: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 129 Spain: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 130 Spain: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 131 Spain: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 132 Spain: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 133 Spain: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 134 Spain: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 135 Spain: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 136 Spain: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 137 Spain: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 138 Rest of Europe: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 139 Rest of Europe: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 140 Rest of Europe: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 141 Rest of Europe: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 142 Rest of Europe: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 143 Rest of Europe: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 144 Rest of Europe: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 145 Rest of Europe: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 146 Rest of Europe: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 147 Rest of Europe: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 148 Asia-Pacific: High Throughput Screening Market, by Country/Region, 2022–2031 (USD Million)
Table 149 Asia-Pacific: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 150 Asia-Pacific: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 151 Asia-Pacific: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 152 Asia-Pacific: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 153 Asia-Pacific: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 154 Asia-Pacific: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 155 Asia-Pacific: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 156 Asia-Pacific: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 157 Asia-Pacific: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 158 Asia-Pacific: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 159 China: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 160 China: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 161 China: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 162 China: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 163 China: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 164 China: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 165 China: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 166 China: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 167 China: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 168 China: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 169 Japan: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 170 Japan: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 171 Japan: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 172 Japan: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 173 Japan: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 174 Japan: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 175 Japan: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 176 Japan: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 177 Japan: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 178 Japan: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 179 India: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 180 India: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 181 India: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 182 India: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 183 India: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 184 India: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 185 India: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 186 India: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 187 India: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 188 India: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 189 Rest of Asia-Pacific: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 190 Rest of Asia-Pacific: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 191 Rest of Asia-Pacific: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 192 Rest of Asia-Pacific: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 193 Rest of Asia-Pacific: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 194 Rest of Asia-Pacific: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 195 Rest of Asia-Pacific: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 196 Rest of Asia-Pacific: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 197 Rest of Asia-Pacific: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 198 Rest of Asia-Pacific: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 199 Latin America: High Throughput Screening Market, by Country/Region, 2022–2031 (USD Million)
Table 200 Latin America: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 201 Latin America: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 202 Latin America: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 203 Latin America: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 204 Latin America: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 205 Latin America: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 206 Latin America: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 207 Latin America: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 208 Latin America: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 209 Latin America: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 210 Brazil: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 211 Brazil: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 212 Brazil: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 213 Brazil: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 214 Brazil: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 215 Brazil: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 216 Brazil: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 217 Brazil: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 218 Brazil: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 219 Brazil: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 220 Mexico: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 221 Mexico: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 222 Mexico: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 223 Mexico: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 224 Mexico: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 225 Mexico: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 226 Mexico: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 227 Mexico: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 228 Mexico: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 229 Mexico: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 230 Rest of Latin America: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 231 Rest of Latin America: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 232 Rest of Latin America: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 233 Rest of Latin America: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 234 Rest of Latin America: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 235 Rest of Latin America: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 236 Rest of Latin America: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 237 Rest of Latin America: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 238 Rest of Latin America: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 239 Rest of Latin America: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 240 Middle East and Africa: High Throughput Screening Market, by Product, 2022–2031 (USD Million)
Table 241 Middle East and Africa: High Throughput Screening Market, by Cell-based Assays, 2022–2031 (USD Million)
Table 242 Middle East and Africa: High Throughput Screening Market, by 3D Cell Culture, 2022–2031 (USD Million)
Table 243 Middle East and Africa: High Throughput Screening Market, by Scaffold Based Technology, 2022–2031 (USD Million)
Table 244 Middle East and Africa: High Throughput Screening Market, by Natural Polymer Hydrogels, 2022–2031 (USD Million)
Table 245 Middle East and Africa: High Throughput Screening Market, by Scaffold Free Technology, 2022–2031 (USD Million)
Table 246 Middle East and Africa: High Throughput Screening Market, by Offering, 2022–2031 (USD Million)
Table 247 Middle East and Africa: High Throughput Screening Instruments Market, by Type, 2022–2031 (USD Million)
Table 248 Middle East and Africa: High Throughput Screening Market, by Application, 2022–2031 (USD Million)
Table 249 Middle East and Africa: High Throughput Screening Market, by End User, 2022–2031 (USD Million)
Table 250 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Global High Throughput Screening Market, by Technology, 2024 VS. 2031 (USD Million)
Figure 8 Global High Throughput Screening Market, by Offering, 2024 VS. 2031 (USD Million)
Figure 9 Global High Throughput Screening Market, by Application, 2024 VS. 2031 (USD Million)
Figure 10 Global High Throughput Screening Market, by End User, 2024 VS. 2031 (USD Million)
Figure 11 Global High Throughput Screening Market, by Geography
Figure 12 Global High Throughput Screening Market, by Technology, 2024 VS. 2031 (USD Million)
Figure 13 Global High Throughput Screening Market, by Offering, 2024 VS. 2031 (USD Million)
Figure 14 Global High Throughput Screening Market, by Application, 2024 VS. 2031 (USD Million)
Figure 15 Global High Throughput Screening Market, by End User, 2024 VS. 2031 (USD Million)
Figure 16 Global High Throughput Screening Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 17 North America: High Throughput Screening Market Snapshot
Figure 18 Europe: High Throughput Screening Market Snapshot
Figure 19 Asia-Pacific: High Throughput Screening Market Snapshot
Figure 20 Latin America: High Throughput Screening Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 22 Global High Throughput Screening Market: Competitive Benchmarking, by Technology
Figure 23 Global High Throughput Screening Market: Competitive Dashboard
Figure 24 Global High Throughput Screening Market: Market Share Analysis/Market Ranking (2023)
Figure 25 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
Figure 26 Agilent Technologies, Inc.: Financial Snapshot (2023)
Figure 27 Merck KGaA: Financial Snapshot (2023)
Figure 28 Danaher Corporation: Financial Snapshot (2023)
Figure 29 Bio-Rad Laboratories, Inc.: Financial Snapshot (2023)
Figure 30 Revvity Inc.: Financial Snapshot (2023)
Figure 31 Tecan Group Ltd.: Financial Snapshot (2023)
Figure 32 Charles River Laboratories International, Inc.: Financial Snapshot (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Newborn Screening Market - Global Opportunity Analysis And Industry Forecast (2024-2031)
Published Date: Jan-2024
Europe NGS Market - Opportunity Analysis and Industry Forecasts (2024-2030)
Published Date: Jul-2024
